Tandem Autologous Stem Cell Transplants (auto-auto) With or without Maintenance Therapy Versus Single Autologous Transplant Followed by HLA-Matched Sibling Non- Myeloablative Allogeneic Stem Cell Transplant (auto-allo) for Patients (pts) with High Risk (HR) Multiple Myeloma (MM): Results From the Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0102 Trial 52nd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) Stadtmauer, E. A., Krishnan, A., Pasquini, M. C., Ewell, M., Alyea, E. P., Antin, J. H., Castro-Malaspina, H., Kassim, A. A., Negrin, R., Qazilbash, M. H., Rizzo, J. D., Rowley, S. D., Sahebi, F., Somlo, G., Vesole, D. H., Vogl, D. T., Weisdorf, D. J., Geller, N., Horowitz, M. M., Maloney, D. G., Giralt, S. AMER SOC HEMATOLOGY. 2010: 233–34

View details for Web of Science ID 000289662200527